Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

1 terminated/withdrawn out of 60 trials

Success Rate

97.4%

+10.9% vs industry average

Late-Stage Pipeline

10%

6 trials in Phase 3/4

Results Transparency

3%

1 of 37 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A
20(60.6%)
Phase 2
5(15.2%)
Phase 4
3(9.1%)
Phase 3
3(9.1%)
Early Phase 1
2(6.1%)
33Total
N/A(20)
Phase 2(5)
Phase 4(3)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (60)

Showing 20 of 60 trials
NCT07517731Not ApplicableCompleted

Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities

Role: lead

NCT07290725Enrolling By Invitation

Cross-cultural Adaptation and Translation Validation of the iADH Universal Case Mix Tool (UCMT).

Role: collaborator

NCT07430501Not Yet Recruiting

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Role: collaborator

NCT00947362Phase 2Completed

Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul

Role: collaborator

NCT07053631Not ApplicableRecruiting

Investigation of a New Window Into Intracranial Pressure: Venous Occlusion Pressure of the Isolated Periorbital Vein

Role: lead

NCT04753788Completed

Evaluation of a LAMP Assay for T. Pallidum. Pertenue

Role: collaborator

NCT06301412Phase 3Recruiting

Combination of Hypothermia and Thrombectomy in Acute Stroke

Role: lead

NCT04522843Completed

Analysis of Intestinal Defensin Expression in Acute GVHD

Role: lead

NCT06323434Recruiting

Spinal CSF Leaks in Chronic Subdural Hematoma

Role: lead

NCT05988047Completed

Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia

Role: lead

NCT02509286Phase 3Active Not Recruiting

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus

Role: collaborator

NCT06074874Completed

Intestinal Biomarker Analysis After ECP for ICI Colitis

Role: lead

NCT05638724Recruiting

Munich Long COVID Registry for Children, Adolescents, and Adults

Role: collaborator

NCT04558788Completed

Cellular Stress Reactions During Graft-versus-host Disease

Role: lead

NCT04290429Early Phase 1Completed

Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

Role: lead

NCT04038996Completed

The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors

Role: lead

NCT05414552Completed

ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

Role: lead

NCT05811117Completed

Multicenter Study Using IMC to Analyze the Impact of ICANS on Microglia

Role: lead

NCT04526964Not ApplicableCompleted

Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3

Role: lead

NCT01711931Phase 4Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents

Role: lead